share_log

科前生物(688526.SH):上交所决定终止对公司定增的审核

Keqian Biotech (688526.SH): The Shanghai Stock Exchange decided to stop reviewing the company's fixed increase

Gelonghui Finance ·  Jul 2, 2023 05:45

Gelonghui July 2?688526.SH announced that on June 30, 2023, the company received a "decision on terminating the examination and approval of Wuhan Keqian Biology Co., Ltd. to issue shares to specific targets" (SSE Review (refinancing) [2023] No.161). In accordance with the relevant provisions of Article 19 of the rules on the examination and approval of Securities issuance and listing of listed companies on the Shanghai Stock Exchange and Article 63 (2) of the rules on the examination and approval of Stock issuance and listing of Shanghai Stock Exchange, it is decided to terminate the examination and approval of the company's issuance of shares to specific targets.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment